Home > Healthcare > Medical Services > Diagnostic Services > HbA1c Testing Market

HbA1c Testing Market Trends

  • Report ID: GMI9631
  • Published Date: May 2024
  • Report Format: PDF

HbA1c Testing Market Trends

  • Technological advancements, such as the development of point-of-care testing devices, are enhancing convenience and efficiency, allowing for rapid, real-time glucose monitoring. Additionally, the increased adoption of self-testing kits, accelerated by the COVID-19 pandemic, is empowering patients to manage their diabetes more effectively from home. The global rise in diabetes prevalence, driven by lifestyle factors and an aging population, is significantly boosting demand for these tests.
     
  • Furthermore, the market is benefiting from government initiatives and regulatory support promoting regular diabetes screening and monitoring. Emerging markets in Asia and Latin America are also contributing to growth due to improved healthcare access and rising healthcare expenditures. Innovations in testing methods, including non-invasive options, and integration with mobile health platforms are further enhancing patient compliance and data management. These trends collectively indicate a robust and expanding market poised for continued advancement.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Market size for HbA1c testing was valued at USD 2.3 billion in 2023 and is estimated to grow at 8.6% CAGR from 2024 to 2032 due to factors, such as the increasing prevalence of diabetes and technological advancements, alongside the development of novel testing methodologies.

The point-of-care (POC) testing segment of the HbA1c testing market is forecasted to reach USD 3.5 billion by 2032 due to the increasing demand for accessible diabetes management, advancements in testing technology, and personalized healthcare.

The immunoassays segment of the HbA1c testing industry accounted for USD 817.1 million in 2023 due to rising diabetes prevalence, technological advancements, and the demand for efficient point-of-care solutions.

Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Ceragem Medisys Inc., Danaher Corporation, EKF Diagnostics, F. Hoffmann-La Roche Ltd., HUMAN, Menarini Diagnostics s.r.l, and PTS Diagnostics, among others.

HbA1c Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 220
  • Countries covered: 23
  • Pages: 230
 Download Free Sample